Site Map Site Map of http://www.researchandmarkets.com - Site Map - Pharmaceuticals and Healthcare    - Pharmaceuticals 1 (Latest Titles)    Pharmaceuticals 2    Pharmaceuticals 3    Pharmaceuticals 4       - Markets  << You are in This Category #  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z   # 2006 Industry Dynamics: Lessons to Be Learned static version printer friendly pdf version ^ Top A A Guide to Biosimilars, Biogenerics and Follow-On Biologics static version printer friendly pdf version A Guidebook to Pharma Brand Optimization: Lifecycle Management Strategy static version printer friendly pdf version A Product Director’s Guide to Promotional Mix static version printer friendly pdf version Achieving Market Dominance Through Reformulation: A Strategic Insight static version printer friendly pdf version Adhd Market: Pestel Analysis and Scenario Based Forecasts static version printer friendly pdf version Advanced Wound Management Markets in South Korea static version printer friendly pdf version Allergic Conjunctivitis: A Specialized Market static version printer friendly pdf version Atherosclerosis: Strategic Audit of Marketplace Activity Issues and Implications static version printer friendly pdf version ^ Top B Biotechnology & Pharmaceuticals Sector in China (Beijing Region) static version printer friendly pdf version Blockbuster Pharmaceutical Launches: Establishing Market Leadership static version printer friendly pdf version ^ Top C Cardiovascular Therapy US Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles static version printer friendly pdf version Cardiovascular Therapy Worldwide Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles static version printer friendly pdf version Changing Role of Medicare and its Impact on Pharmaceutical Industry static version printer friendly pdf version China Anti-tumor Drugs Market Report 2007 static version printer friendly pdf version China Anti-tumor Drugs Market Report, 2007 static version printer friendly pdf version China Medicated Health Product Industry Report 2007 static version printer friendly pdf version China Medicated Health Product Industry Report, 2007 static version printer friendly pdf version China Medipharm Insights static version printer friendly pdf version China Pharmaceutical Industry Report 2006-2007 static version printer friendly pdf version China Pharmaceutical Industry Report, 2006-2007 static version printer friendly pdf version Chinese Pharmaceutical Industry static version printer friendly pdf version CNS European Market Competitive Strategies - Competitive Analysis, Profiles and Portfolio Strategies of the Top 20 CNS Therapeutic Manufacturers in Europe (2001 Edition) static version printer friendly pdf version CNS Market: Year in Review - Sales Overview and Market News, 2000 static version printer friendly pdf version Commercial Insight: HIV in the USA - Increasing Choice, Flexibility and Competition static version printer friendly pdf version Cost Effective Healthcare Solutions The Strategic Impact of Pharmacoeconomics in Key Markets static version printer friendly pdf version Country Industry Forecast - The Brazilian Healthcare Industry static version printer friendly pdf version Cox-ii Inhibitors: Comparison of Global Markets and Factors Influencing Performance static version printer friendly pdf version Critical Success Factors in Market Launch: Maximizing revenues through effective penetration strategies static version printer friendly pdf version ^ Top D Dermatological Therapeutics: Business Opportunities and Threats in Rx and OTC Markets (2001) static version printer friendly pdf version Developing the High-Performance Market Research Function static version printer friendly pdf version Development of the Medicine Circulation Industry in China - Pharmaceutical Wholesale and Distribution in China static version printer friendly pdf version Direct-to-Consumer Marketing of Prescription Pharmaceuticals in Europe static version printer friendly pdf version Drug Repositioning Strategies: Innovative Strategies to Boost Pipeline Productivity static version printer friendly pdf version Drugs of Tomorrow 2000: Arthritis - Developments For a Competitive Market static version printer friendly pdf version Drugs of Tomorrow 2001: Antipsychotics - New Players in an Expanding Market static version printer friendly pdf version Drugs of Tomorrow 2001: Migraine - Impact of the Novel Triptan Class on Acute Treatment Market static version printer friendly pdf version ^ Top E Early-Stage Pharmaceutical Marketing Budgets: Preparing for Product Launch static version printer friendly pdf version eCME: Leveraging Online Continuing Medical Education as a Channel of Influence static version printer friendly pdf version Emerging CV Market: Cell Transplant Therapies - The End of the Beginning static version printer friendly pdf version Emerging Pharmaceutical Markets: Growth Opportunities, Changing Healthcare Dynamics and Regulatory Trends static version printer friendly pdf version Emerging Trends and Innovations in Biomechatronics (Technical Insights) static version printer friendly pdf version Epidemiology-Based Market Forecasting: Pros and Cons static version printer friendly pdf version EU Paediatric Medicines Regulation: Boon or Burden? static version printer friendly pdf version European Autoimmune Diseases Therapeutics Markets static version printer friendly pdf version European Immunochemistry Analysers Markets static version printer friendly pdf version European Interventional Radiology Markets static version printer friendly pdf version European Ophthalmic Pharmaceuticals Markets static version printer friendly pdf version European Pain Management Pharmaceutical Markets static version printer friendly pdf version European Testosterone Replacement Therapies Markets static version printer friendly pdf version European Urinary Incontinence Therapeutics Markets static version printer friendly pdf version ^ Top G Global Biopharmaceutical Contract Manufacturing Markets static version printer friendly pdf version ^ Top H HIV Update 2001 (2): Midyear Market Analysis and Forecasts static version printer friendly pdf version HIV: Future Treatment Directions - A Strategic Analysis of Market Developments and Opportunities static version printer friendly pdf version How to React to Parallel Trade static version printer friendly pdf version ^ Top I Indian Biotechnology Industry - Emerging Opportunities static version printer friendly pdf version Indian Generics, 2008-2012: The Growing Threat to Westernised Markets static version printer friendly pdf version Indian Pharmaceutical Industry: The Changing Prescription static version printer friendly pdf version Indian Pharmaceuticals Industry static version printer friendly pdf version Industry Analysis - Changing Dynamics in Worldwide Psychiatric Franchises static version printer friendly pdf version Innovations in Drug Delivery Within the Respiratory Market: The Key to Effective Lifecycle Management? static version printer friendly pdf version Internet Infrastructure: Exploring Emerging Healthcare Markets static version printer friendly pdf version ^ Top J Japanese Cancer Market: Who Will Emerge Ahead? static version printer friendly pdf version Japanese Market Entry Strategies: Best Practice Recommendations for Maximum Return on Investment static version printer friendly pdf version ^ Top L Leveraging the Internet in Product Launch: Strategies for Improved Poitioning in Varying Market Conditions static version printer friendly pdf version Licensing Strategies: Benchmarking Analysis of the Top 20 Pharmaceutical Companies static version printer friendly pdf version Lifestyle Drugs Market Outlook: Key Indications, Epidemiology, and Emergent Drugs static version printer friendly pdf version ^ Top M Managed Markets 2007: Pharmaceutical Reimbursement Strategy, Organizational Structure and Medicare Part D static version printer friendly pdf version Market Dynamics 2000: Allergic Rhinitis: Effects of Major Patent Expiries On An Expanding Market static version printer friendly pdf version Market Dynamics 2000: Migraine - Dominance of Triptans in the Global Market static version printer friendly pdf version Market Dynamics 2000: Vaccines - The Ultimate Form of Protection static version printer friendly pdf version Market Dynamics 2001: Alzheimer''s Disease - An expanding market driven by Aricept static version printer friendly pdf version Market Dynamics 2001: Anti-Cancer Innovatives Series static version printer friendly pdf version Market Dynamics 2001: Anti-Dyslipidemics - Life Beyond Lipid Lowering static version printer friendly pdf version Market Dynamics 2001: Anti-emetics static version printer friendly pdf version Market Dynamics 2001: Anti-hypertensives - Aiirbs battle for supremacy static version printer friendly pdf version Market Dynamics 2001: Anticoagulants - The Advent of a New Generation of Agents static version printer friendly pdf version Market Dynamics 2001: Antidepressants - Absorbing the Impact of Generic Prozac static version printer friendly pdf version Market Dynamics 2001: Antiplatelets and Thrombolytics - Combination therapies key to market development static version printer friendly pdf version Market Dynamics 2001: Bacterial Infections static version printer friendly pdf version Market Dynamics 2001: Cytotoxics static version printer friendly pdf version Market Dynamics 2001: Diabetes static version printer friendly pdf version Market Dynamics 2001: Hepatitis B&C - The Succession of New Generation Therapies static version printer friendly pdf version Market Dynamics 2001: Hormonals static version printer friendly pdf version Market Dynamics 2002: Anti-Cancer Innovatives Series Part II - Angiogenesis Inhibitors static version printer friendly pdf version Market Dynamics 2002: Anti-Cancer Innovatives Series Part III - Gene Therapies static version printer friendly pdf version Market Dynamics: Anti-asthmatics - Preparing for Slow Market Growth static version printer friendly pdf version Market Dynamics: Emerging Markets in Spinal Implants static version printer friendly pdf version Market Dynamics: Emerging Markets in Total Knee Replacement static version printer friendly pdf version Market Dynamics: Hyaluronic Acid Viscosupplementation - Market Flourishes Despite End-User Skepticism static version printer friendly pdf version Market Dynamics: Japanese Orthopaedics - A Bull Amongst the Bears static version printer friendly pdf version Market Dynamics: Knee Arthroplasty - The Battle Between Parsimony and Technology static version printer friendly pdf version Medicines for Hypertension Prevention and Cure in China static version printer friendly pdf version MIS Urological Market, 2005-2011 static version printer friendly pdf version Monoclonal Antibodies 2007: Competitive Landscape & Pipeline Insight static version printer friendly pdf version Monoclonal Antibodies Report Part II: Companies - Holding mAbs in portfolio promises protection against the looming 2011-12 patent cliff static version printer friendly pdf version Monoclonal Antibody Therapeutics: Current Market Dynamics & Future Outlook static version printer friendly pdf version ^ Top O Obesity Therapeutics: Understanding Market Dynamics (Presentation) static version printer friendly pdf version Obsessive-Compulsive Disorder: Strategies to Maximize Opportunities in a Small Market static version printer friendly pdf version Outlook for the Migraine Market With Novel Approaches Limited, Triptans Dominate static version printer friendly pdf version ^ Top P Pharmaceutical Competitive Intelligence: Expanding the Role and Reach of CI static version printer friendly pdf version Pharmaceutical Pricing and Reimbursement in the United States static version printer friendly pdf version Pharmaceutical Pricing and Reimbursement: Strategies for Market Access Across the US, Europe, Japan and Other Key Geographies static version printer friendly pdf version Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Fourth Quarter of 2006 static version printer friendly pdf version Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Third Quarter of 2006 static version printer friendly pdf version Pharmaceutical Product Relaunch: Preserving Market Share through Line Extension and New Market Entry Strategies  static version printer friendly pdf version Pharmaceutical Regulatory Affairs in the EU & US static version printer friendly pdf version Pharmaceutical Reimbursement Strategies: Maximizing Revenue Potential in Europe, US and Japan static version printer friendly pdf version Pharmaceutical Sales Management 2008 static version printer friendly pdf version Pharmaceuticals Industry in India static version printer friendly pdf version Pharmacoeconomics and Health Outcomes: Driving Formulary Access and Reimbursement static version printer friendly pdf version Pipeline And Commercial Insight: Influenza Vaccines - Pandemic Threat Revitalizes The Sector static version printer friendly pdf version Pipeline Insight: Antithrombotics - Reaching The Untreated Prophylaxis Market static version printer friendly pdf version Pipeline Insight: Osteoporosis - Intermittent Dosing Drives Market Growth static version printer friendly pdf version Post-Launch Brand Marketing in Select Affiliate Markets static version printer friendly pdf version Pricing & Reimbursement in Asia-Pacific static version printer friendly pdf version Pricing & Reimbursement Series: Medicare Part Ds Progress So Far static version printer friendly pdf version Pricing and Reimbursement Issues for Immune Disease Therapies static version printer friendly pdf version Promotion to Pharmacists: Towards a Direct Selling Development static version printer friendly pdf version ^ Top R Reputation Monitor: the Pharmaceutical Industry static version printer friendly pdf version Respiratory Therapy European Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles static version printer friendly pdf version ^ Top S Sabinsa Case Study: Successfully Marketing Weight-Loss Supplements static version printer friendly pdf version Sector Snapshot: Statin Drug Markets static version printer friendly pdf version Stakeholder Opinions: Fibromyalgia - Potentially Lucrative Market Soon To Become Reality static version printer friendly pdf version State of the Pharmaceutical Industry, 2007 static version printer friendly pdf version Strategic Analysis of the Brazilian Pharmaceutical Markets static version printer friendly pdf version Strategic Perspectives 2001: Menopausal Disorders and Osteoporosis - Aging and Awareness Drive Market Growth static version printer friendly pdf version Strategic Perspectives 2001: Narcolepsy - Specific Drugs are Waking up the Market static version printer friendly pdf version Strategic Perspectives 2001: Obesity - An Old Market Attracting New Attention static version printer friendly pdf version Strategic Perspectives 2001: Obsessive Compulsive Disorder - A Developed Market Still Attracting New Entrants static version printer friendly pdf version Strategic Perspectives 2001: Portfolio Management in the Anti-Fungal Market static version printer friendly pdf version Strategic Perspectives 2001: Restless Legs Syndrome - A Market Driven by Demographics static version printer friendly pdf version Strategic Perspectives 2001: Social Anxiety Disorder - The Target Anxiety Market For Leading Players static version printer friendly pdf version Strategic Perspectives 2001: The Antiviral Market - A Market For Expanding Indications static version printer friendly pdf version Strategic Perspectives 2001: The Copd Market - Gaining A New Identity static version printer friendly pdf version Strategic Perspectives: Oncology licensing strategies - how will targeted therapies affect the licensing market? static version printer friendly pdf version Substance Abuse Disorders: A focus on the smoking cessation and alcohol addiction markets static version printer friendly pdf version ^ Top T The Anemia Market: Biogenerics and Second-Generation Products Drive Change static version printer friendly pdf version The Chinese hepatitis B market - Overcoming hurdles to investment static version printer friendly pdf version The eHealth Market in France: A Look at Market Specific Issues, Trends and Implications static version printer friendly pdf version The eHealth Market in Germany: A Look at Market Specific Issues, Trends and Implications static version printer friendly pdf version The eHealth Market in the UK: A Look at Market Specific Issues, Trends and Implications static version printer friendly pdf version The Emerging eHealth Market in Japan: Capitalizing on Opportunities to Reach Physicians Online static version printer friendly pdf version The Emerging Sepsis Market - Risky Business Benefits From High Rewards static version printer friendly pdf version The Evolution of DTC marketing across key pharmaceutical markets static version printer friendly pdf version The Evolving ePrescribing Market Players: Strategies for Successful Partnerships static version printer friendly pdf version The Gastrointestinal Market Outlook to 2012 static version printer friendly pdf version The Genomics Outlook To 2005: Transforming Pharmaceutical And Diagnostic Markets static version printer friendly pdf version The Global Antivirals Market: R&D Pipelines, Market Analysis and Competitive Landscape static version printer friendly pdf version The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007 static version printer friendly pdf version The Global Market for AntiMicrobials and Antifungals; Challenging Resistance to 2015 static version printer friendly pdf version The Global Protein Therapeutics Market static version printer friendly pdf version The Infectious Disease Market in 2001: A Year in Review static version printer friendly pdf version The Japanese Pharmaceutical Market Outlook 2001 static version printer friendly pdf version The Lifestyle Drugs Outlook To 2007: Challenges And Opportunities In A High-Profile Growth Market static version printer friendly pdf version The Pharmaceutical Market: Argentina static version printer friendly pdf version The Pharmaceutical Market: Australia static version printer friendly pdf version The Pharmaceutical Market: Austria static version printer friendly pdf version The Pharmaceutical Market: Bangladesh static version printer friendly pdf version The Pharmaceutical Market: Belgium static version printer friendly pdf version The Pharmaceutical Market: Brazil 2008 static version printer friendly pdf version The Pharmaceutical Market: Bulgaria static version printer friendly pdf version The Pharmaceutical Market: Canada static version printer friendly pdf version The Pharmaceutical Market: Chile static version printer friendly pdf version The Pharmaceutical Market: China static version printer friendly pdf version The Pharmaceutical Market: Colombia static version printer friendly pdf version The Pharmaceutical Market: Croatia static version printer friendly pdf version The Pharmaceutical Market: Cuba static version printer friendly pdf version The Pharmaceutical Market: Czech Republic static version printer friendly pdf version The Pharmaceutical Market: Denmark static version printer friendly pdf version The Pharmaceutical Market: Egypt static version printer friendly pdf version The Pharmaceutical Market: Estonia static version printer friendly pdf version The Pharmaceutical Market: Finland static version printer friendly pdf version The Pharmaceutical Market: France static version printer friendly pdf version The Pharmaceutical Market: Germany static version printer friendly pdf version The Pharmaceutical Market: Greece static version printer friendly pdf version The Pharmaceutical Market: Hong Kong static version printer friendly pdf version The Pharmaceutical Market: Hungary - 2007 Update static version printer friendly pdf version The Pharmaceutical Market: India static version printer friendly pdf version The Pharmaceutical Market: Indonesia static version printer friendly pdf version The Pharmaceutical Market: Ireland static version printer friendly pdf version The Pharmaceutical Market: Israel static version printer friendly pdf version The Pharmaceutical Market: Italy static version printer friendly pdf version The Pharmaceutical Market: Japan static version printer friendly pdf version The Pharmaceutical Market: Jordan - 2007 Update static version printer friendly pdf version The Pharmaceutical Market: Latvia static version printer friendly pdf version The Pharmaceutical Market: Lithuania static version printer friendly pdf version The Pharmaceutical Market: Malaysia static version printer friendly pdf version The Pharmaceutical Market: Mexico static version printer friendly pdf version The Pharmaceutical Market: Morocco static version printer friendly pdf version The Pharmaceutical Market: Netherlands static version printer friendly pdf version The Pharmaceutical Market: New Zealand static version printer friendly pdf version The Pharmaceutical Market: Pakistan static version printer friendly pdf version The Pharmaceutical Market: Peru static version printer friendly pdf version The Pharmaceutical Market: Philippines static version printer friendly pdf version The Pharmaceutical Market: Poland static version printer friendly pdf version The Pharmaceutical Market: Portugal static version printer friendly pdf version The Pharmaceutical Market: Romania static version printer friendly pdf version The Pharmaceutical Market: Russia static version printer friendly pdf version The Pharmaceutical Market: Saudi Arabia static version printer friendly pdf version The Pharmaceutical Market: Serbia static version printer friendly pdf version The Pharmaceutical Market: Singapore static version printer friendly pdf version The Pharmaceutical Market: Slovakia static version printer friendly pdf version The Pharmaceutical Market: Slovenia static version printer friendly pdf version The Pharmaceutical Market: South Africa static version printer friendly pdf version The Pharmaceutical Market: South Korea static version printer friendly pdf version The Pharmaceutical Market: Spain static version printer friendly pdf version The Pharmaceutical Market: Sweden static version printer friendly pdf version The Pharmaceutical Market: Switzerland static version printer friendly pdf version The Pharmaceutical Market: Taiwan static version printer friendly pdf version The Pharmaceutical Market: Thailand static version printer friendly pdf version The Pharmaceutical Market: Turkey static version printer friendly pdf version The Pharmaceutical Market: UK static version printer friendly pdf version The Pharmaceutical Market: Ukraine static version printer friendly pdf version The Pharmaceutical Market: USA static version printer friendly pdf version The Pharmaceutical Market: Venezuela static version printer friendly pdf version The Pharmaceutical Market: Vietnam static version printer friendly pdf version The Rationale Behind Drug Reformulation: Five Case Studies and Overview of CNS Market and R&D static version printer friendly pdf version